Probucol as a potent inhibitor of oxygen radical-induced lipid peroxidation and DNA damage: In vitro studies

Redox Report

Volumn 9, Issue 3, 2004, Pages 167-172

  Iqbal, Mohammad ^a   Sharma, Som Datta ^b   Okada, Shigeru ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF DELHI   (India)

Author keywords

Carcinogenesis; DNA damage; Lipid peroxidation; Probucol

Indexed keywords

ANTIOXIDANT; DNA; HYDROGEN PEROXIDE; HYDROXYL RADICAL; HYPOCHOLESTEROLEMIC AGENT; LIPID; NITRILOTRIACETATE IRON; OXYGEN RADICAL; PROBUCOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DNA DAMAGE; DRUG STRUCTURE; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; INCUBATION TIME; INHIBITION KINETICS; KIDNEY CARCINOMA; KIDNEY MICROSOME; KIDNEY NECROSIS; KIDNEY PROXIMAL TUBULE; LIPID PEROXIDATION; MALE; MICROSOME MEMBRANE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; CARCINOGENS; DNA DAMAGE; FERRIC COMPOUNDS; FREE RADICALS; HYDROGEN PEROXIDE; KIDNEY; LIPID PEROXIDATION; MALE; MICE; MOLECULAR STRUCTURE; NITRILOTRIACETIC ACID; OXIDANTS; PROBUCOL; REACTIVE OXYGEN SPECIES;

ANIMALIA; RODENTIA;

EID: 4544289358     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100004225005174     Document Type: Article

References (44)

1. Tappel AL. Lipid peroxidation damage to cell components. Fed Proc 1973; 32: 1870-1874.
2. Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 1979; 59: 527-605.
3. Sies, H. Biochemistry of oxidative stress. Angew Chem Int Engl 1986; 25: 1058-1071.
4. Cheeseman KH, Slater TF. An introduction to free radical biochemistry. Br Med Bull 1993; 49: 481-493.
5. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988; 240: 1302-1309.
6. Aruoma OI, Halliwell B, Gajewski E, Dizdaroglu M. Damage to the bases in DNA induced by hydrogen peroxide and ferric ion chelates. J Biol Chem 1989; 264: 20509-20512.
7. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
8. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parental administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979; 95: 663-673.
9. Okada S, Midorikawa O. Induction of rat renal adenocarcinoma by ferric nitrilotriacetate. Jpn Arch Intern Med 1982; 29: 485-491.
10. Okada S. Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int 1996; 46: 311-332.
11. Hiroyasu M, Ozeki M, Kohda H, Echizenya M, Tanaka T, Hiai H, Toyokuni S. Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 2002; 160: 419-424.
12. Iqbal M, Giri U, Athar M. Ferric nitrilotriacetate (Fe-NTA) is a potent hepatic tumor promoter and acts through the generation of oxidative stress. Biochem Biophys Res Commun 1995; 212: 557-563.
13. Athar M, Iqbal M. Ferric nitrilotriacetate promotes N-diethyl nitrosoamine-induced renal tumorigenesis in rat: implications for the involvement of oxidative stress. Carcinogenesis 1998; 19: 1133-1139.
14. Iqbal M, Sharma SD, Rahman A, Trikha P, Athar M. Evidence that ferric nitrilotriacetate mediates oxidative stress by down-regulating DT-diaphorase activity: implications for carcinogenesis. Cancer Lett 1999; 141: 151-157.
15. Iqbal M, Giri U, Giri DK, Athar M. Evidence that Fe-NTA induced renal prostaglandin F2α is responsible for hyperplastic response in kidney: implications for the role of cyclooxygenase-dependent arachidonic acid metabolism in renal tumor promotion. Biochem Mol Biol Int 1997; 42: 1115-1124.
16. Iqbal M, Giri U, Giri DK, Alam MS, Athar M. Age dependent renal accumulation of 4-hydroxy-2-nonenal (HNE)-modified proteins following parental administration of ferric nitrilotriacetate commensurate with its differential toxicity: implications for the involvement of HNE-protein adducts in oxidative stress and carcinogenesis. Arch Biochem Biophys 1999; 365:101-112.
17. Iqbal M, Sharma SD, Mizote A, Fujisawa M, Okada S. Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate-mediated DNA damage: implications for carcinogenesis. Teratog Carcinog Mutagen 2003; 1: 13-21.
18. Hartwig A, Klyszez-Nasko H, Schlepegrell R, Beyersmann D. Cellular damage by ferric nitrilotriacetate and ferric citrate in V79 cells: interrelationship between lipid peroxidation, DNA strand breaks and sister chromatid exchanges. Carcinogenesis 1993; 14: 107-112.
19. Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H. Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 1997; 57: 2410-2414.
20. Iqbal M, Rezazadeh H, Ansar S, Athar M. α-Tocopherol (vitamin-E) ameliorates ferric nitrilotriacetate (Fe-NTA)-dependent renal proliferative response and toxicity: diminution of oxidative stress. Hum Exp Toxicol 1998; 17: 163-171.
21. Iqbal M, Athar M. Attenuation of iron-nitrilotriacetate mediated renal oxidative stress, toxicity and hyperproliferative response by the prophylactic treatment of rats with garlic oil. Food Chem Toxicol 1998; 36: 485-495.
22. Ansar S, Iqbal M, Athar M. Nordihydroguaretic acid is a potent inhibitor of ferric nitrilotriacetate mediated hepatic and renal toxicity and renal tumor promotion in mice. Carcinogenesis 1999; 20: 599-606.
23. Kimoto T, Koya S, Hino K et al. Renal carcinogenesis induced by ferric nitrilotriacetate in mice, and protection from it by Brazilian propolis and Artepillin C. Pathol Int 2000; 50: 679-689.
24. Matos HR, Capelozzi VL, Gomes OF, Mascio PD, Medeiros MH. Lycopene inhibits DNA damage and liver necrosis in rats treated with ferric nitrilotriacetate. Arch Biochem Biophys 2001; 396: 171-177.
25. 2)-induced peroxidation of microsomal membrane lipids and DNA damage. Teratog Carcinog Mutagen 2003; 1: 151-160.
26. Zimetbaum P, Eder H, Frishman W. Probucol: pharmacology and clinical application. J Clin Pharmacol 1990; 30: 3-9.
27. Kuzuya M, Kuzuya F. Probucol as an antioxidant and antiatherogenic drug. Free Radic Biol Med 1993; 14: 67-77.
28. Bridges AB, Scott NA, Belch JJ. Probucol, a superoxide free radical scavenger in vitro. Atherosclerosis 1991; 89: 263-265.
29. Hiramatsu M, Liu J, Edamatsu R, Ohba S, Kadowaki D, Mori A. Probucol scavenged 1,1-diphenyl-2-picrylhydrazyl radicals and inhibited formation of thiobarbituric acid reactive substances. Free Radic Biol Med 1994; 16: 201-206.
30. Dage RC, Anderson BA, Mao SJ, Koerner JE. Probucol reduces myocardial dysfunction during reperfusion after short-term ischemia in rabbit heart. J Cardiovasc Pharmacol 1991; 17: 158-165.
31. Bird JE, Milhoan K, Wilson CB et al. Ischemic acute renal failure and antioxidant therapy in rat. The relation between glomerular and tubular dysfunction. J Clin Invest 1988; 81: 1630-1638.
32. Siveski-Iliskovic N, Hill M, Chow DA, Singal PK. Probucol protects against adriamycin cardiomyopathy without interfering with its antitumor effect. Circulation 1995; 91: 10-15.
33. Parthasarathy S. Evidence for an additional intracellular site of action of probucol in the prevention of oxidative modification of low-density lipoprotein. Use of a new water-soluble probucol derivative. J Clin Invest 1992; 89: 1618-1621.
34. Wright JR, Colby HD, Miles PR. Cytosolic factors, which affect microsomal lipid peroxidation in lung and liver. Arch Biochem Biophys 1981; 206: 296-304.
35. Athar M, Iqbal M, Beg MU, Al-Ajmi D, Al-Muzaini S. Airborne dust collected from Kuwait in 1991-1992 augments peroxidation of cellular membrane lipids and enhances DNA damage. Environ Int 1998; 24: 205-212.
36. Toyokuni S, Uchida K, Okamato K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994; 91: 2616-2620.
37. Haklar G, Sirikci O, Ozer NK, Yalcin AS. Measurement of reactive oxygen species by chemiluminescence in diet-induced atherosclerosis: protective roles of vitamin E and probucol on different radical species. Int J Clin Lab Res 1998; 28: 122-126.
38. Ito M, Suzuki Y, Ishibara M, Suzuki Y. Anti-ulcer effects of antioxidants: effect of probucol. Eur J Pharmacol 1998; 354: 189-196.
39. Gotoh N, Shimizu K, Komuro E, Tsuchiya J, Noguchi N, Nikki E. Antioxidant activities of probucol against lipid peroxidations. Biochim Biophys Acta 1992; 1128: 147-154.
40. Qin X, Zhang S, Zarkovic M et al. Inhibitory effect of probucol on nephrotoxicity induced by ferric nitrilotriacetate (Fe-NTA) in rats. Carcinogenesis 1995; 16: 2549-2552.
41. Zarkovic M, Qin X, Nakatsuru Y et al. Inhibitory effect of probucol on benzo[a]pyrene induced lung tumorigenesis. Carcinogenesis 1995; 16: 2599-2601.
42. Nishimura G, Yanoma S, Mizuno H, Kawakami K, Tsukuda M. An antioxidant, probucol, induces anti-angiogenesis and apoptosis in athymic nude mouse xenografted human head and neck squamous carcinoma cells. Jpn J Cancer Res 1999; 90: 1224-1230.
43. El-Demerdash E, El-Denshary E, El-Didi M, Al-Gharabli N, Osman AM. Probucol and liver efficiency during chemically-induced hepatocarcinogenesis. Anticancer Res 2002; 22: 977-984.
44. Iliskovic N, Hasinoff BB, Malisza KL, Danelisen I, Singal PK. Mechanisms of beneficial effects of probucol in adriamycin cardiomyopathy. Mol Cell Biochem 1999; 196: 43-49.